Skip to main content
. 2017 Jun 29;8(38):63646–63664. doi: 10.18632/oncotarget.18882

Table 2. Primer sequences used in this study.

Gene Assay Sequence
LEFTY1 Promoter Forward 5′-TGCTAGGCACCCTGTAGACA-3′
Reverse 5′-AAGGCTGCAGGAGGGTCTCA-3′
mRNA Forward 5′-CTGCTGATGGACAAATGCTCTG-3′
/ISH probe Reverse 5′-ACTTTAGCCCAGATCCAGTGAC-3′
Methylation Forward 5′-TAGTTTTTAAGGTTTAGGGTGTG-3′
Reverse 5′-TACTAACCCTACTCTTATCCC-3′
sh 1207-1229 Forward 5′-GATCCCGACTTGTGTGTGTTTCTGAAGGCTTCC
TGTCACCTTCAGAAACACACACAAGTCTTTTTTG-3′
Reverse 5′-AATTCAAAAAAGACTTGTGTGTGTTTCTGAAGG
TGACAGGAAGCCTTCAGAAACACACACAAGTCGG-3′
LEFTY2 Promoter Forward 5′-TTCCCTGTTCTTCAAACACCGTCC-3′
Reverse 5′-TCCTCTAGGGAGGTTGAAGGAGG-3′
mRNA Forward 5′-TCTAACTGAACGTGTGCATAG-3′
/ISH probe Reverse 5′-GAAGAATTTGCCAGAGAACAG-3′
XIAP mRNA Forward 5′-GCTAACTGATTGGAAGCCC-3′
Reverse 5′-GTCCTTGAAACTGAACCCC-3′
Promoter Forward 5′-CTAGGTCAGCTTCTCGGTTCCAG-3′
Reverse 5′-GAGAAACCCGGAGTCGTGAAACC-3′

ISH, in situ hybridization; sh, short-hairpin.